Topics

ANAVEX LIFE SCIENCES Company Profile

08:57 EDT 18th July 2019 | BioPortfolio

Anavex Life Sciences Corp. ( www.anavex.com ) is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological diseases. The company's proprietary SIGMACEPTOR(TM) Discovery Platform involves the rational drug design of compounds that fulfill specific criteria based on unmet market needs and new scientific advances. Selected drug candidates demonstrate high, non-exclusive affinity for sigma receptors, which are involved in the modulation of multiple cellular biochemical signaling pathways.

ANAVEX's SIGMACEPTOR(TM)-N program involves the development of novel and original drug candidates, targeting neurological and neurodegenerative diseases (Alzheimer's disease, epilepsy, depression, etc.). The company's lead drug candidates exhibit high, non-exclusive affinity for sigma receptors with strong evidence for anti-amnesic, neuroprotective, anti-apoptotic, anti-oxidative, anti-inflammatory, anti-convulsive, anti-depressant and anxiolytic properties.

ANAVEX's SIGMACEPTOR(TM)-C program involves the development of novel and original drug candidates targeting cancer. The company's lead drug candidates exhibit high, non-exclusive affinity for sigma receptors with strong evidence for selective pro-apoptotic, anti-metastatic and low toxicity properties in various types of solid cancers such as colon, prostate, breast, lung, etc.

Location

14, Rue Kleberg
Geneva
CH-1201
Switzerland

Contact

Phone: (416) 489-0092
Email: ir@anavex.com


News Articles [2260 Associated News Articles listed on BioPortfolio]

Anavex Life Sciences Doses First Patient in Phase 2 Clinical Trial of ANAVEX®2-73 for the Treatment of Rett Syndrome

Anavex Life Sciences (NASDAQ:AVXL) has announced it has dosed its first patient in its AVATAR Phase 2 trial of ANAVEX2-73 to treat Rett syndrome. As quoted in the press release: ANAVEX®2-73 has alrea...

Anavex Life Sciences Doses First Patient in Extension Study to US Phase 2 Clinical Trial of ANAVEX2-73

Anavex Life Sciences (NASDAQ:AVXL) has announced that the first patient that completed the Phase 2 clinical trial ANAVEX2-73-RS-001 has moved into the extension study for treatment of Rett syndrome. A...

Anavex Life Sciences advancing its Parkinson's disease therapy through the pipeline

Anavex Life Sciences Corp (NASDAQ:AVXL) President and CEO Christopher Missling sat down with Proactive Investors at the BIO CEO & Investor Conference in New York. The biopharmaceutical company...

Anavex Life Sciences (AVXL) Presents At BIO CEO & Investor Conference - Slideshow

Anavex Life Sciences' (AVXL) CEO Christopher Missling on Q2 2019 Results - Earnings Call Transcript

Anavex Life Sciences Corp. (AVXL) CEO Christopher Missling on Q4 2018 Results - Earnings Call Transcript

Anavex Life Sciences Corp. (AVXL) CEO Christopher Missling on Q1 2019 Results - Earnings Call Transcript

Anavex Life Sciences doses patients in Phase 2 ANAVEX2-73 Parkinson disease dementia study

The biotech also has clinical programs for the drug for the treatment of Alzheimer’s disease and Rett Syndrome, a rare neurological disorder that occurs mainly in girls

Drugs and Medications [45 Associated Drugs and Medications listed on BioPortfolio]

Mondoxyne nl 100mg [oculus innovative sciences]

Monodoxyne NL 100mg

Mondoxyne [oculus innovative sciences]

Mondoxyne NL 50mg

Deltasone [oculus innovative sciences]

Deltasone 20mg prednisone tablets

Complera access [gilead sciences, inc.]

These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA™ (emtricitabine, rilpivirine, tenofovir dis...

Emtriva [gilead sciences, inc.]

These highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule, for oral use EMTRIVA (e...

PubMed Articles [2835 Associated PubMed Articles listed on BioPortfolio]

Genetically Modified Organisms in Developing Countries: Risk Analysis and Governance.

Introduction to the Special Issue on Biotechnological Frontiers.

Short-term disability fluctuations in late life.

Late-life disability is highly dynamic but within-person short-term fluctuations have not been assessed previously. We analyze how substantial such late-life disability fluctuations are and whether th...

Greater Peri-Aortic Fat Volume at Midlife is Associated with Slower Gait Speed Later in Life in Women: The SWAN Cardiovascular Fat Ancillary Study.

Higher perivascular adipose tissue (PVAT) contributes to adverse physiologic alterations in the vascular wall, and thus could potentially limit normal physical function later in life. We hypothesize t...

Anticipating Emerging Biotechnology Threats: .

This article discusses the contingencies and complexities of CRISPR. It outlines key problems regarding off-target effects and replication of experimental work that are important to consider in light ...

Clinical Trials [2524 Associated Clinical Trials listed on BioPortfolio]

Advance Care Planning at London Health Sciences Centre

All patients admitted to London Health Sciences Centre (LHSC) are asked to indicate their preferences for CPR (cardiopulmonary resuscitation) and other life-sustaining treatments that nece...

M-learning to Improve Professional Competencies in Health Sciences

The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.

Assessment of the Burden Within the Dyad Patient/Caregiver

This study is about the patients life ending and their caregiver, when a return to home is planned. This is a behavioral sciences study (= interventional study for french law)

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

Companies [2064 Associated Companies listed on BioPortfolio]

Anavex Life Sciences Corp.

Anavex Life Sciences Corp. (www.anavex.com) is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and...

ANAVEX LIFE SCIENCES

Anavex Life Sciences Corp. ( www.anavex.com ) is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological disea...

Life Sciences Pennsylvania

Life Sciences Pennsylvania is the statewide trade association for the life sciences in Pennsylvania and serves as a catalyst to ensure Pennsylvania is a global leader in the life ...

Blackstone Life Sciences

Blackstone Life Sciences is a private investment platform with capabilities to invest across the life-cycle of companies and products within the key life science sectors. By combi...

Central Life Sciences

Central Life Sciences is a strategic business unit of Central Garden & Pet (NASDAQ: CENT). Central Life Sciences is dedicated to creating healthier environments and making life better for people, ...

More Information about "ANAVEX LIFE SCIENCES" on BioPortfolio

We have published hundreds of ANAVEX LIFE SCIENCES news stories on BioPortfolio along with dozens of ANAVEX LIFE SCIENCES Clinical Trials and PubMed Articles about ANAVEX LIFE SCIENCES for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ANAVEX LIFE SCIENCES Companies in our database. You can also find out about relevant ANAVEX LIFE SCIENCES Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record